Close this search box.

Cancer trial participant hoping to help

The RAVES trial treating prostate cancer Participating in a clinical trial, like the TROG Cancer Research RAVES trial, often means more than just accessing new technology that could increase treatment and quality of life outcomes. For people like James, it’s about using an understandably challenging situation to help others.

Oncology breakthrough reveals better treatments for prostate cancer patients

Paving the way for success in prostate cancer treatment, TROG Cancer Research are helping to reduce common side effects and the length of treatment with the TROG 15.01 SPARK Trial. The clinical trial, led by Professor Paul Keall and Professor Jarad Martin, proposes the use of kilovoltage intrafraction monitoring (KIM) alongside stereotactic body radiotherapy (SBRT) to provide

New study identifies more effective prostate cancer imaging

Prostate cancer is one of the most common cancers amongst men, with one in six men diagnosed before their 85th birthday (Cancer Australia). In fact, in 2019 alone over 19,000 men in Australia were diagnosed with prostate cancer. The high rate of prostate cancer diagnosis in Australian men has led this to